Cargando…
Metformin Can Alleviate the Symptom of Patient with Diabetic Nephropathy Through Reducing the Serum Level of Hcy and IL-33
BACKGROUND: Interleukin-33 (IL-33) and homocysteine (Hcy) were found to be up-regulated in patients with diabetic nephropathy (DN), and the present study aimed to investigate whether metformin (MT) can influence the serum levels of IL-33 and Hcy in patients with DN. METHODS: Sixty patients with type...
Autores principales: | Zhang, Ling, Niu, Jiansheng, Zhang, Xiumei, He, Wanxia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
De Gruyter
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6731542/ https://www.ncbi.nlm.nih.gov/pubmed/31535033 http://dx.doi.org/10.1515/med-2019-0071 |
Ejemplares similares
-
Effect of donepezil on Hcy level in serum of Alzheimer's disease patients and correlation analysis of Hcy and dyssomnia
por: Liu, Xinxin, et al.
Publicado: (2019) -
Propofol alleviates inflammation and apoptosis in HCY-induced HUVECs by inhibiting endoplasmic reticulum stress
por: Ji, Cunliang, et al.
Publicado: (2021) -
Diagnostic Value of the Combined Measurement of Serum HCY and NRG4 in Type 2 Diabetes Mellitus with Early Complicating Diabetic Nephropathy
por: Ding, Sheng, et al.
Publicado: (2023) -
Diagnostic Value of the Combined Measurement of Serum Hcy, Serum Cys C, and Urinary Microalbumin in Type 2 Diabetes Mellitus with Early Complicating Diabetic Nephropathy
por: Wang, Tengkai, et al.
Publicado: (2013) -
HCI Beyond the GUI
por: Kortum, Philip
Publicado: (2008)